NewYou can listen to Fox News articles now!
A new study uncovers another potential approach Prevention at 19 years old.
Researchers at the University of Sarland, Germany, led a clinical trial that found that nasal sprays can reduce the risk of coronavirus infection by two-thirds.
this Phase 2 studyPublished at JAMA Internal Medicine at University Hospital of Sarland from March 2023 to July 2024.
New Covid variants could cause “razor blade throat” – Here’s what to know
450 healthy adult participants were randomly assigned to receive intravenous nasal spray or placebo three times a day for 56 days.
The researchers performed a rapid antigen test for SARS-COV-2 twice a week to diagnose the infection. People with symptoms but receiving negative antigen test results have undergone multiple PCR tests Respiratory virus.
According to new research, Azelastine nasal spray has the potential to delay infection in 19009. (iStock)
Among the 227 individuals receiving the Azelastine nasal spray, the confirmed COVID infection rate was “significantly reduced” at 2.2%, compared with 6.7% in the placebo group.
Click here to sign up for our health newsletter
The researchers also pointed out that people taking Azelastine had an increase in the period before infection. In these patients, the drug was confirmed with PCR and confirmed symptomatic infections with fewer rhinovirus infections (the main reason) Common cold).
Researchers found that azana spray may also help prevent other respiratory viruses. (iStock)
“In this single-center trial, Azelastine nasal spray “It is associated with a reduced risk of SARS-COV-2 respiratory infection,” the researchers wrote.
Azelastine has been used as an over-the-counter treatment for hay fever, which has previously recommended antiviral effects on COVID and other people, according to a press release from Saarland University. Respiratory Virus.
Click here to get the Fox News app
Professor Robert Bals, director of internal medicine at the University of Sarland Medical Center, commented in a statement that the trial proved Azelastine’s influence in “the real world”.
The study says Ascelastin leads to a decrease in the number of symptomatic infections confirmed by PCR. (iStock)
“Azelastine nasal sprays can provide additional, easily accessible preventiveness to complement existing protections, especially for vulnerable groups, during high periods Infection rate Or before traveling,” he continued.
For more health articles, please visit www.foxnews.com/health
“Our results highlight the need for large, multicenter trials to continue exploring the use of Azelastine nasal spray as an on-demand preventive treatment and to examine its potential effectiveness against other respiratory pathogens.”
Fox News Digital contacted researchers for comment.
